Throughout 2017, the ATS Public Advisory Roundtable (PAR) is hosting its seventh annual "Lung Disease Week at the ATS" series, a society-wide initiative that recognizes the many rare lung disorders for which ATS PAR member organizations provide support and guidance to patients and their families. For a series of oneweek periods, ATS PAR brings patient issues to the front and center of the Society's agenda. Working with its PAR partners, the ATS develops, aggregates, and hosts links to disease-specifi c content on its web site
Feb 5-11—Rare Lung DiseasesPAR Partner — Jack Kelly |
Mar 5-11—LAMPAR Partner — Mary Harbaugh (LAM Foundation) |
Mar 19-25—Tuberous Sclerosis ComplexPAR Partner — Kari Rosbeck (Tuberous Sclerosis Alliance) |
Apr 2-8—SarcoidosisPAR Partner — Ginger Spitzer |
Apr 16-22—Cystic Fibrosis*PAR Partner — Beth Sufi an (Cystic Fibrosis Foundation) |
Jun 4-10—Scleroderma*PAR Partner — Kerri Connolly (Scleroderma Foundation) |
Jun 18-24—Critical CareATS Leader — Rolf Hubmayr, MD |
Aug 6-12—Asthma and Allergy NetworkPAR Partner — Tonya Winders |
Aug 20-26—Alpha-1/COPDPAR Partner — Karen Erickson (Alpha-1 Foundation) |
Sep 10-16—Nontuberculous Mycobacteria (NTM)*PAR Partner — Susan Wisliceny (NTM Info & Research) |
Sep 24-30—chILDPAR Partner — Greg Porta (chILD Foundation) |
Oct 8-14—Primary Ciliary Dyskinesia (PCD)PAR Partner — Michele Manion (PCD Foundation) |
Oct 22-28—Lung TransplantPAR Partner — Jeff Goldstein (Lung Transplant Foundation) |
Nov 12-18—Pulmonary HypertensionATS Leader — Karen Fagan, MD |
* Will also include an in-the-fi eld patient education day event
For more information on Lung Disease Week at the ATS, please contact Courtney L. White, CAE, Director of Patient Outreach & Tobacco Control at cwhite@thoracic.org or (212) 315-8640.